WASHINGTON, Feb 15 (Reuters) - U.S. health regulators on Friday issued proposed guidelines that would make it easier for pharmaceutical companies to advise doctors about unapproved uses for their drugs. Read full article below.
WASHINGTON, Feb 15 (Reuters) - U.S. health regulators on Friday issued proposed guidelines that would make it easier for pharmaceutical companies to advise doctors about unapproved uses for their drugs. Read full article below.
